Pacer Advisors’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $1.65M | Sell |
|
|||||
|
2025
Q2 | $1.73M | Buy |
|
|||||
|
2025
Q1 | $387K | Sell |
|
|||||
|
2024
Q4 | $754K | Sell |
|
|||||
|
2024
Q3 | $1.06M | Buy |
|
|||||
|
2024
Q2 | $1.06M | Buy |
|
|||||
|
2024
Q1 | $951K | Buy |
|
|||||
|
2023
Q4 | $808K | Sell |
|
|||||
|
2023
Q3 | $1.39M | Buy |
|
|||||
|
2023
Q2 | $1.3M | Buy |
|
|||||
|
2023
Q1 | $760K | Buy |
|
|||||
|
2022
Q4 | $39.4K | Sell |
|
|||||
|
2022
Q3 | $8.59M | Buy |
|
|||||
|
2022
Q2 | $588K | Buy |
|
|||||
|
2022
Q1 | $750K | Buy |
|
|||||
|
2021
Q4 | $970K | Sell |
|
|||||
|
2021
Q3 | $1.71M | Sell |
|
|||||
|
2021
Q2 | $1.54M | Sell |
|
|||||
|
2021
Q1 | $1.54M | Sell |
|
|||||
|
2020
Q4 | $1.35M | Sell |
|
|||||
|
2020
Q3 | $2.58M | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.53M | Sell |
|
|||||
|
2019
Q3 | $2.36M | Sell |
|
|||||
|
2019
Q2 | $2.72M | Buy |
|
|||||
|
2019
Q1 | – | Sell |
|
|||||
|
2018
Q4 | $20K | Sell |
|
|||||
|
2018
Q3 | $2.32M | Buy |
|
|||||
|
2018
Q2 | $1.7M | Buy |
|
|||||
|
2018
Q1 | $1.4M | Buy |
|
|||||
|
2017
Q4 | $1.22M | Buy |
|
|||||
|
2017
Q3 | $782K | Buy |
|
|||||
|
2017
Q2 | $635K | Buy |
|
|||||
|
2017
Q1 | $505K | Buy |
|
|||||
|
2016
Q4 | $350K | Buy |
|
|||||
|
2016
Q3 | $357K | Buy |
|
|||||
|
2016
Q2 | $323K | Buy |
|